Neuroinflammatory Mechanisms of Vascular Cognitive Impairment
血管性认知障碍的神经炎症机制
基本信息
- 批准号:10753185
- 负责人:
- 金额:$ 165.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AgeAge MonthsAgingAnti-Inflammatory AgentsAutopsyB-LymphocytesBiological AvailabilityBlood - brain barrier anatomyBlood PreservationBlood VesselsBlood brain barrier dysfunctionBrainCellsCerebrovascular CirculationCholesterolChronicClinicalCognitiveCognitive deficitsDementiaDependenceDevelopmentDiabetes MellitusDyslipidemiasElderlyEmotionalEncephalitisEndothelial CellsEndotheliumEpidemiologyEpoxide hydrolaseExhibitsFamilyFemaleFinancial HardshipFlow CytometryHealthcare SystemsHigh Fat DietHistopathologyHumanHyperlipidemiaHypertensionImmuneImmunohistochemistryImpaired cognitionInfiltrationInflammatoryInvadedLeucocytic infiltrateLeukocytesLifeLinkLipidsLoxP-flanked alleleMagnetic Resonance ImagingMapsMeasurementMetabolicMetabolic DiseasesMetabolic syndromeMicrovascular DysfunctionModelingMusNeurocognitive DeficitNeutrophil InfiltrationObesityPatientsPeripheralProcessPropertyPublic HealthRecording of previous eventsReporterRiskRisk FactorsRoleSeveritiesSex DifferencesSignaling MoleculeTestingTherapeuticTimeUp-RegulationVascular Cognitive ImpairmentVascular EndotheliumVentricularWild Type Mouseage relatedagedblood-brain barrier crossingblood-brain barrier disruptionblood-brain barrier permeabilizationbrain parenchymabrain tissuecardiovascular risk factorcerebral atrophycerebrovascularcognitive testingenzyme activityglial activationhuman old age (65+)immune cell infiltrateinhibitorinnovationmalemiddle agemorris water mazeneuroinflammationnovelobject recognitionoverexpressionpharmacologicpreventresponsesecondary outcomesingle-cell RNA sequencingtranslational studytreatment effectwhite matter damage
项目摘要
ABSTRACT
Aging-related dementia is a major public health concern that places an enormous emotional, physical, and
financial stress on patients, their families and health-care systems. Clinical and epidemiological evidence
suggests that the presence of vascular and metabolic risk factors, such as obesity, diabetes, dyslipidemia and
hypertension, collectively known as the metabolic syndrome (MetS), during midlife increases the risk for and
severity of dementia in late-life. The proposed studies will use the chronic high-fat diet (HFD) model of MetS in
mice to investigate the mechanism and age-dependency of MetS-related cognitive dysfunction (MetSCD).
Our observations made in postmortem human brain with a history of dementia and in brains of HFD-fed mice
suggest that MetS increases the expression and activity of the enzyme soluble epoxide hydrolase (sEH) in brain
microvascular endothelium, leading to reduced bioavailability of its substrate epoxyeicosatrienoates (EETs),
which have anti-inflammatory properties. Reduced endothelial EETs predisposes to endothelial cell activation,
peripheral immune cell infiltration into brain parenchyma, neuroinflammation and cognitive dysfunction. In
support of a causal link between sEH upregulation, neuroinflammation and cognitive impairment, mice with
endothelial overexpression of human sEH exhibit age-dependent neuroinflammation and cognitive deficit, while
pharmacological inhibition of sEH protects against HFD-induced neuroinflammation and cognitive impairment.
We will test the hypothesis that MetS contributes to late-life cognitive dysfunction via the infiltration of
peripheral immune cells and progressive neuroinflammation. Aim 1 will use male and female wild-type (WT)
mice and mice with endothelial-specific deletion of sEH, on standard (STD) or high-fat diet (HFD), to determine
the role of endothelial sEH in MetSCD at 12 and 24 months of age. Aim 2 will use flow cytometry,
immunohistochemistry (IHC) and single-cell RNAseq (scRNAseq) to determine if HFD induces an age-
dependent neuroinflammatory response characterized by early infiltration of neutrophils and delayed infiltration
of T and B lymphocytes. We will use immune cell reporter mice (Fgd5-CreERT2;Ai9) to confirm the peripheral
origin of leukocytes, characterize the time course of immune cell invasion, and determine if endothelial-specific
deletion of sEH prevents immune cell infiltration into the brain of mice on HFD. Aim 3 will determine if sEH
inhibitors t-AUCB (brain-penetrant) and
GSK2256294 (does not cross the blood-brain barrier, BBB)
protect
against neurocognitive impairment in mice on chronic HFD. We will also determine if there are sex differences
in treatment effects. The proposed studies are highly translational, and will advance understanding of
mechanisms and age-dependency MetSCD. The endothelial origin of age-dependent immune cell infiltration in
MetSC is novel, and so is the use of scRNAseq and immune cell fate mapping using Fgd5-CreERT2; Ai9 mice.
摘要
与衰老相关的痴呆症是一个主要的公共卫生问题,
对病人、其家庭和保健系统造成经济压力。临床和流行病学证据
表明存在血管和代谢危险因素,如肥胖、糖尿病、血脂异常和
高血压,统称为代谢综合征(MetS),在中年增加的风险,
老年痴呆症的严重程度。拟议的研究将使用MetS的慢性高脂饮食(HFD)模型,
目的:探讨代谢综合征相关认知功能障碍(MetS-related cognitive dysfunction,MetSCD)的发病机制及年龄依赖性。
我们在有痴呆症病史的人死后大脑和喂食HFD的小鼠大脑中进行了观察
表明MetS增加脑中可溶性环氧化物水解酶(sEH)的表达和活性
微血管内皮,导致其底物环氧二十碳三烯酸酯(ESTs)的生物利用度降低,
具有抗炎作用。降低的内皮细胞活化倾向于内皮细胞活化,
外周免疫细胞向脑实质的浸润、神经炎症和认知功能障碍。在
支持sEH上调、神经炎症和认知障碍之间的因果关系,
人sEH的内皮过表达表现出年龄依赖性神经炎症和认知缺陷,
sEH的药理学抑制可防止HFD诱导的神经炎症和认知损害。
我们将检验代谢综合征通过以下途径导致老年认知功能障碍的假设:
外周免疫细胞和进行性神经炎症。Aim 1将使用雄性和雌性野生型(WT)
小鼠和内皮特异性缺失sEH的小鼠,接受标准(STD)或高脂饮食(HFD),以确定
内皮sEH在12和24月龄时MetSCD中的作用。Aim 2将使用流式细胞术,
免疫组织化学(IHC)和单细胞RNAseq(scRNAseq),以确定HFD是否诱导年龄-
依赖性神经炎性反应,特征为中性粒细胞的早期浸润和延迟浸润
T和B淋巴细胞。我们将使用免疫细胞报告小鼠(Fgd 5-CreERT 2; Ai 9)来确认外周血淋巴细胞的表达。
白细胞的起源,表征免疫细胞侵袭的时间过程,并确定内皮特异性
sEH的缺失防止免疫细胞浸润到HFD小鼠的脑中。目标3将确定sEH
抑制剂t-AUCB(脑渗透剂)和
GSK 2256294(不穿过血脑屏障,BBB)
保护
对抗慢性HFD小鼠的神经认知障碍。我们还将确定是否存在性别差异
治疗效果。拟议的研究是高度翻译,并将促进了解
机制和年龄依赖性MetSCD。年龄依赖性免疫细胞浸润的内皮起源
MetSC是新颖的,使用scRNAseq和使用Fgd 5-CreERT 2; Ai 9小鼠的免疫细胞命运作图也是新颖的。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cytochrome P450-derived eicosanoids in brain: From basic discovery to clinical translation.
大脑中细胞色素 P450 衍生的类二十烷酸:从基础发现到临床转化。
- DOI:10.1016/bs.apha.2022.11.002
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Davis,CatherineM;Ibrahim,AseelH;Alkayed,NabilJ
- 通讯作者:Alkayed,NabilJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nabil J Alkayed其他文献
Nabil J Alkayed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nabil J Alkayed', 18)}}的其他基金
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
GPR39 作为衰老相关血管认知障碍和痴呆的治疗靶点
- 批准号:
10734713 - 财政年份:2023
- 资助金额:
$ 165.9万 - 项目类别:
Training in Translational Science and Cardiovascular Research
转化科学和心血管研究培训
- 批准号:
10711526 - 财政年份:2023
- 资助金额:
$ 165.9万 - 项目类别:
Soluble Epoxide Hydrolase Inhibitor GSK2256294 for Acute Ischemic Stroke
可溶性环氧化物水解酶抑制剂 GSK2256294 用于治疗急性缺血性中风
- 批准号:
10672750 - 财政年份:2023
- 资助金额:
$ 165.9万 - 项目类别:
GPR39 as a Therapeutic Target in Subarachnoid Hemorrhage (SAH)
GPR39 作为蛛网膜下腔出血 (SAH) 的治疗靶点
- 批准号:
10478533 - 财政年份:2022
- 资助金额:
$ 165.9万 - 项目类别:
Role of GPR39 in Aging-Related Vascular Cognitive Impairment (VCI)
GPR39 在衰老相关血管认知障碍 (VCI) 中的作用
- 批准号:
10538329 - 财政年份:2022
- 资助金额:
$ 165.9万 - 项目类别:
Endothelial-Pericyte Crosstalk in Diabetic Stroke
糖尿病中风的内皮-周细胞串扰
- 批准号:
10400506 - 财政年份:2021
- 资助金额:
$ 165.9万 - 项目类别:
Pericyte phenotypic switching in diabetic post-stroke cognitive impairment (PSCI)
糖尿病中风后认知障碍(PSCI)中的周细胞表型转换
- 批准号:
10855709 - 财政年份:2018
- 资助金额:
$ 165.9万 - 项目类别:
Endothelial-Pericyte Crosstalk in Diabetic Stroke
糖尿病中风的内皮-周细胞串扰
- 批准号:
10338161 - 财政年份:2018
- 资助金额:
$ 165.9万 - 项目类别:
Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)
衰老相关血管性认知障碍(VCI)的神经炎症机制
- 批准号:
9461247 - 财政年份:2017
- 资助金额:
$ 165.9万 - 项目类别:
DRα1-MOG: A Novel Immunomodulatory Therapeutic for Stroke
DRα1-MOG:一种新型中风免疫调节疗法
- 批准号:
9409245 - 财政年份:2017
- 资助金额:
$ 165.9万 - 项目类别:














{{item.name}}会员




